Stocks of the Hour: Immutep, Chimeric Therapeutics, Sayona Mining
Immutep (ASX:IMM; NASDAQ:IMMP) announced that their Efti, a soluble LAG-3 protein, in Combination with KEYTRUDA®, generates excellent overall survival benefit in patients with metastatic non-small cell lung cancer. In response, Marc Voigt, Immutep CEO stated, “the strength of the data positions us well as we continue to plan and prepare for our Phase III trial […]
Stocks of the Hour: Immutep, Chimeric Therapeutics, Sayona Mining Read More »